MI
ZVSAW

MMCAP International’s ZyVersa Therapeutics, Inc. Warrants ZVSAW Stock Holding History

MMCAP International’s Portfolio ZVSAW Stock Details ZVSAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-277,500
Closed -$33K – 428
2022
Q3 		$33K Hold
277,500
– – ﹤0.01% 328
2022
Q2 		$30K Hold
277,500
– – ﹤0.01% 371
2022
Q1 		$48K Buy
+277,500
New +$56.2K ﹤0.01% 437

MMCAP International's ZVSAW Position: Q4 2022 in Review

MMCAP International sold out of ZyVersa Therapeutics, Inc. Warrants (ZVSAW) in Q4 2022, closing a stake of 277,500 shares — an estimated $33K sold.

MMCAP International first reported a position in ZVSAW in Q1 2022 and held it in 3 quarters. The position peaked at $48K in Q1 2022. 1 fund tracked by Wall St. Rank holds ZVSAW as of Q4 2022.

  • MMCAP International reported no remaining ZyVersa Therapeutics, Inc. Warrants position as of Q4 2022 after selling out during the quarter.
  • MMCAP International sold 277,500 ZyVersa Therapeutics, Inc. Warrants shares in Q4 2022, an estimated $33K.
  • MMCAP International first reported a position in ZyVersa Therapeutics, Inc. Warrants in Q1 2022 and held it in 3 quarters.
  • MMCAP International's ZyVersa Therapeutics, Inc. Warrants position peaked at $48K in Q1 2022.
  • 1 fund tracked by Wall St. Rank held ZyVersa Therapeutics, Inc. Warrants as of Q4 2022.

Based on MMCAP International's 13F filing for Q4 2022, filed 9 Feb 2023.